News | December 09, 2011

Maquet Restructures U.S. Sales, Services Organization to Hybrid OR Focus

December 9, 2011 — Maquet announced Thursday it has restructured its U.S. Sales and Services Unit to meet the broader needs of customers across all areas of clinical care. As part of this restructuring, the company now offers a comprehensive disease therapy team dedicated to servicing customers who are building a hybrid operating room (OR).

An estimated 100 hospitals in the United States currently have a hybrid OR, and the number is expected to increase by 15 percent or more over the next few years. As a top investment made by hospitals today and with approximately 60 percent of all U.S. hospitals planning for one, they represent a rapidly growing market.

"In a hybrid OR, the cath lab doubles as an operating room so a patient undergoing a cardiac catheterization procedure can be quickly moved to surgery if required," explains Niv Ad, M.D., chief of cardiac surgery, director of cardiac surgery research, Inova Heart and Vascular Institute, Fairfax, Va. "Hybrid ORs offer the potential for improved patient outcomes, as they allow physicians to perform a full range of procedures within one setting and eliminate the need to move a critically ill patient to a different room of the hospital."

Maquet's new Hybrid Surgery Group will partner with Philips Medical and Siemens Medical to provide comprehensive therapy solutions for this growing market. These will include a surgical table that can be fully integrated with the imaging system; as well as ceiling booms; cardiac perfusion pumps; intra-aortic balloon pumps; anesthesia systems; surgical lights; and OR data integration for advanced surgical suite control.

The company has launched a new website — MAQUET-HybridOperatingRoom.com -- that provides information about planning, implementing, building and equipping a highly complex hybrid OR. The website also includes information about specific equipment and multimedia features such as a slideshow, images, videos and downloadable resources.

A hybrid OR is a state-of-the-art operating suite housing all of the equipment and monitoring devices necessary to perform open heart surgeries, such as coronary artery bypass grafting (CABG); and percutaneous coronary interventions (PCI) and procedures, including angioplasty and stenting.

Many patients suffering from coronary artery disease (CAD) can be treated less invasively in a hybrid OR, rather than going straight to a traditional operating room for CABG surgery. Containing both an OR and a cardiac catheterization lab, a hybrid OR offers an opportunity to combine minimally invasive cardiac surgery with PCI; this eliminates the need to move a critically ill patient to a different room on a different floor of the hospital.

Because hybrid ORs contain sophisticated imaging equipment, patients do not have to be sent to separate imaging suites, which is more efficient and safer for patients. They also facilitate collaboration between specialists, such as cardiologists, cardiac surgeons, interventional radiologists and vascular surgeons. The result is more efficient workflows, optimized processes and streamlined, coordinated patient care. As hybrid ORs are expected to lead to better patient outcomes and shorter lengths of stay, they could result in significant cost savings to the overall healthcare system.

For more information: www.maquet.com

Related Content

Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Overlay Init